CN102872074B - Houttuynoid C在治疗肾癌药物中的应用 - Google Patents
Houttuynoid C在治疗肾癌药物中的应用 Download PDFInfo
- Publication number
- CN102872074B CN102872074B CN201210417095.8A CN201210417095A CN102872074B CN 102872074 B CN102872074 B CN 102872074B CN 201210417095 A CN201210417095 A CN 201210417095A CN 102872074 B CN102872074 B CN 102872074B
- Authority
- CN
- China
- Prior art keywords
- houttuynoid
- kidney cancer
- drugs
- application
- renal carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- FCUIRBQXJWMGLZ-YLUJEXTNSA-N 2-(3-decanoyl-7-hydroxy-1-benzofuran-4-yl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound C=12C(C(=O)CCCCCCCCC)=COC2=C(O)C=CC=1C=1OC2=CC(O)=CC(O)=C2C(=O)C=1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O FCUIRBQXJWMGLZ-YLUJEXTNSA-N 0.000 title claims abstract description 44
- 206010038389 Renal cancer Diseases 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 208000008839 Kidney Neoplasms Diseases 0.000 title abstract description 8
- 229940079593 drug Drugs 0.000 title abstract description 8
- 201000010982 kidney cancer Diseases 0.000 title abstract description 8
- 208000006265 Renal cell carcinoma Diseases 0.000 claims description 17
- 201000010174 renal carcinoma Diseases 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000012010 growth Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 abstract description 2
- OAVCWZUKQIEFGG-UHFFFAOYSA-O 2-(5-methyl-2H-tetrazol-1-ium-1-yl)-1,3-thiazole Chemical compound CC1=NN=N[NH+]1C1=NC=CS1 OAVCWZUKQIEFGG-UHFFFAOYSA-O 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 239000003560 cancer drug Substances 0.000 abstract 1
- 208000009889 Herpes Simplex Diseases 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 4
- 230000003602 anti-herpes Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 240000000691 Houttuynia cordata Species 0.000 description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229930190556 houttuynoid Natural products 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210417095.8A CN102872074B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid C在治疗肾癌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210417095.8A CN102872074B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid C在治疗肾癌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872074A CN102872074A (zh) | 2013-01-16 |
CN102872074B true CN102872074B (zh) | 2014-04-16 |
Family
ID=47473745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210417095.8A Active CN102872074B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid C在治疗肾癌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872074B (zh) |
-
2012
- 2012-10-27 CN CN201210417095.8A patent/CN102872074B/zh active Active
Non-Patent Citations (2)
Title |
---|
Houttuynoids A-E, Anti-Herpes Simplex Virus Active Flavonoids with Novel Skeletons from Houttuynia cordata;Shao-Dan Chen, et al.;《ORGANIC LETTERS》;20120313;第14卷(第7期);1772-1775 * |
Shao-DanChen et al..Houttuynoids A-E |
Also Published As
Publication number | Publication date |
---|---|
CN102872074A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102861099B (zh) | Houttuynoid D在制备治疗子宫内膜癌药物中的应用 | |
CN102861073B (zh) | Houttuynoid A在治疗结直肠癌药物中的应用 | |
CN102872074B (zh) | Houttuynoid C在治疗肾癌药物中的应用 | |
CN102872072B (zh) | Houttuynoid B在治疗肾癌药物中的应用 | |
CN102872073B (zh) | Houttuynoid C在制备治疗卵巢癌药物中的应用 | |
CN102861080B (zh) | Houttuynoid C在制备治疗鼻咽癌药物中的应用 | |
CN102861052B (zh) | Houttuynoid A在制备治疗回盲肠癌药物中的应用 | |
CN102872135B (zh) | Houttuynoid D在治疗肾癌药物中的应用 | |
CN102872142B (zh) | Houttuynoid D在制备治疗卵巢癌药物中的应用 | |
CN102861074B (zh) | Houttuynoid B在制备治疗膀胱癌药物中的应用 | |
CN102872076B (zh) | Houttuynoid A在治疗舌癌药物中的应用 | |
CN102872070B (zh) | Houttuynoid C在治疗***癌药物中的应用 | |
CN102872080B (zh) | Houttuynoid A在制备治疗***药物中的应用 | |
CN102872138B (zh) | Houttuynoid C在治疗结直肠癌药物中的应用 | |
CN102872085B (zh) | Houttuynoid A在治疗乳腺癌药物中的应用 | |
CN102861062B (zh) | Houttuynoid C在制备治疗子宫内膜癌药物中的应用 | |
CN102872077B (zh) | Houttuynoid B在制备治疗子宫内膜癌药物中的应用 | |
CN102861078B (zh) | Houttuynoid D在制备治疗***癌药物中的应用 | |
CN102861096B (zh) | Houttuynoid E在制备治疗***药物中的应用 | |
CN102861077B (zh) | Houttuynoid D在制备治疗***药物中的应用 | |
CN102872075A (zh) | Houttuynoid E在治疗乳腺癌药物中的应用 | |
CN102861070B (zh) | Houttuynoid E在治疗舌癌药物中的应用 | |
CN102861093B (zh) | Houttuynoid B在治疗结直肠癌药物中的应用 | |
CN102885843B (zh) | Houttuynoid B在治疗乳腺癌药物中的应用 | |
CN102861079B (zh) | Houttuynoid B在制备治疗皮肤癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QIDONG TIANFEN ELECTRIC TOOL TECHNOLOGY INNOVATION Free format text: FORMER OWNER: WU JUNHUA Effective date: 20141126 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 NANJING, JIANGSU PROVINCE TO: 226241 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141126 Address after: Qidong City, Jiangsu province 226241 Nantong lvsigang Tianfen electric tools trade city comprehensive building Patentee after: Qidong Tianfen Electric Tool Technology Innovation Center Address before: 210009 No. 22, Hankou Road, Gulou District, Jiangsu, Nanjing Patentee before: Wu Junhua |